Riskpilot← Back to searchSign inGet full accessFERTILITETSKLINIKKEN TRIANGLEN ApS
APSActiveCVR 17490141Strandvejen 104AMedical specialists activities · NACE 8622Est. 199364 employees
Revenue 2025
DKK 34,8M
+11% vs 2024
EBITDA margin
15.0%
+494% vs 2024
Equity ratio
31.5%
Financial strength
Net profit 2025
DKK 3M
+209% vs 2024
| Revenue | DKK 34,8M | +11% |
| EBITDA | DKK 5,2M | +494% |
| Net profit | DKK 3M | +209% |
| Total assets | DKK 36,8M | -1% |
| Equity | DKK 11,6M | +35% |
| Employees | 64 | — |
Legal name
FERTILITETSKLINIKKEN TRIANGLEN ApS
CVR number
17490141
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
13. december 1993
Share capital
DKK 200.000
Employees
64 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at yde fertilitetsbehandling til patienter, i det omfang sådan behandling ikke er omfattet af den offentlige sygesikring; forskning inden for fertilitet samt anden virksomhed som naturligt er forbundet med fertilitetsbehandling og forskning inden for dette område
Address
Strandvejen 104A
Phone
+4539407000
Email
administration@trianglen.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17.283 | 13.704 | 15.522 | 19.586 | 22.160 | 26.540 | 26.934 | 29.381 | 27.133 | 35.119 | 33.778 | 25.991 | 31.267 | 34.838 |
| Staff expenses | -13.429 | -10.066 | -10.832 | -10.403 | -11.052 | -16.159 | -15.559 | -13.702 | -14.543 | -20.808 | -25.112 | -28.632 | -30.388 | -29.620 |
| EBITDA | 3.854 | 3.639 | 4.691 | 9.184 | 11.108 | 10.381 | 11.375 | 15.679 | 12.590 | 14.311 | 8.666 | -2.641 | 879 | 5.218 |
| Depreciation & amort. | 309 | 503 | 444 | 353 | 318 | -380 | -372 | -428 | -603 | -998 | -1.233 | -2.938 | -3.222 | -2.954 |
| EBIT | 3.544 | 3.136 | 4.247 | 8.831 | 10.790 | 10.001 | 11.003 | 15.251 | 11.988 | 13.312 | 7.433 | -5.580 | -2.343 | 2.264 |
| Net financials | 278 | 621 | 194 | 150 | -7 | 997 | 719 | -30 | -22 | -48 | -88 | 449 | -281 | 1.354 |
| Profit before tax | 3.823 | 3.757 | 4.441 | 8.980 | 10.799 | 10.998 | 11.722 | 15.220 | 11.966 | 13.264 | 7.345 | -5.130 | -2.625 | 3.618 |
| Tax | 966 | 929 | 1.091 | 2.119 | 2.376 | 2.420 | 2.577 | 3.972 | 2.635 | 3.015 | 1.714 | -1.014 | 122 | 636 |
| Net profit | 2.856 | 2.828 | 3.350 | 6.862 | 8.424 | 8.578 | 9.145 | 11.248 | 9.331 | 10.249 | 5.631 | -4.116 | -2.746 | 2.982 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 13.958 | 11.473 | 15.882 | 19.975 | 22.527 | 24.020 | 16.616 | 24.585 | 27.269 | 36.900 | 31.872 | 37.885 | 37.212 | 36.847 |
| Equity | 200 | 200 | 200 | 200 | 8.624 | 8.778 | 357 | 10.439 | 5.371 | 13.595 | 15.476 | 11.360 | 8.614 | 11.596 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 13.758 | 11.273 | 15.682 | 19.775 | 13.903 | 15.189 | 16.178 | 13.113 | 20.889 | 22.312 | 15.354 | 23.853 | 25.441 | 22.147 |
| Total debt | 13.758 | 11.273 | 15.682 | 19.775 | 13.903 | 15.189 | 16.178 | 13.113 | 20.889 | 22.312 | 15.354 | 23.853 | 25.441 | 22.147 |
EBITDA margin
15.0%
This company
15.8%
Market median
-5% vs market
20122025
Equity ratio
31.5%
This company
38.2%
Market median
+18% vs market
20122025
Return on equity
25.7%
This company
18.4%
Market median
+40% vs market
20122025
Net profit margin
8.6%
This company
8.1%
Market median
+6% vs market
20122025
Asset turnover
0.95×
This company
1.12×
Market median
+15% vs market
20122025
Debt / equity
2.18×
This company
0.62×
Market median
-252% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KR Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
MK Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
AL Audit | Audit | 1997 | — | — |
CH Management | Management | 2023 | — | — |
JG Founder | Founder | 1993 | — | — |
| Audit | 1997 | — | — | |
DJ Management | Management | 2025 | — | — |
AC Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
CN Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Chairman | 2018 | — | — | |
| Chairman | 2024 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2018 | |
KÅRE RYGAARD HOLDING ApS | Company | 100.0% | 100.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FERTILITETSKLINIKKEN TRIANGLEN ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kåre Rygaard | Chief Executive Officer | 0 companies |
| Michael Kanstrup-Pedersen | Chief Executive Officer | 0 companies |
| Allan Lucas | Audit | 0 companies |
| Christina Haurum | Management | 0 companies |
| Jørgen Grinsted | Founder | 0 companies |
| Revisionsfirmaet H.P. Larsen's Eftf., Statsaut. revisions- interessentskab | Audit | 0 companies |
| David John Mahony | Management | 0 companies |
| Andrew Came | Chief Executive Officer | 0 companies |
| Christina Norrbom | Chief Executive Officer | 0 companies |
| Glenn Patrick Powers | Board of Directors | 0 companies |
| Susan Channon | Chairman | 0 companies |
| James Gordon Pyne | Chairman | 0 companies |
| Kathryn Marian Munnings | Chairman | 0 companies |
| Richard Banks | Board of Directors | 0 companies |